• helpdesk@Lucintel.com
  • |
  • +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Nanobiotechnology Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the global nanobiotechnology market looks promising with opportunities in pharmaceuticals, medical devices, and medical research. The global nanobiotechnology market is expected to grow with a CAGR of XX% from 2020 to 2025. The major drivers for this market are increasing prevalence of chronic diseases, rising demand for nanobiotechnology in stem cell therapy, and increasing applications of nanobiotechnology.
 
Emerging trends, which have a direct impact on the dynamics of the industry, include  growing adoption of microfabrication for development of miniature biological system and introduction of advanced technologies for treatment of several acute aliments.  

A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global nanobiotechnology market report, please download the report brochure.
 
 



In this market, pharmaceuticals is the largest application of nanobiotechnology. Growth in various segments of the nanobiotechnology market are given below:


 
 



The study includes trends and forecast for the global nanobiotechnology market by application, therapeutics, and region as follows:

By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Pharmaceuticals
  • Medical Devices
  • Medical Research
  • Others
By Therapeutics [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Dental Therapies
  • Cardiac Therapies
  • Orthopedic Therapies
  • Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
    • United States
    • Canada 
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil
Some of the nanobiotechnology companies profiled in this report include Aduro BioTech, Calando Pharmaceuticals, Biosante Phosphate Pharmaceuticals, Celgene, Elan Pharmaceuticals, Flamel Technologies, Nanophase Technologies, Sigma Aldrich, Dendritic Nanotechnologies, and SkyePharma Pharmaceuticals.

Lucintel forecasts that pharmaceuticals will remain the largest segment by application over the forecast period due to increase in expenditure in pharmaceutical and sector.

North America will remain the largest region over the forecast period due to presence of advanced healthcare facilities and infrastructure that can easily adopt nanobiotechnology. 



 
Features of the Global Nanobiotechnology Market
 
  • Market Size Estimates: Global nanobiotechnology market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global nanobiotechnology market size by various segments, such as application and therapeutics in terms of value.
  • Regional Analysis: Global nanobiotechnology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different application, therapeutics, and region for the global nanobiotechnology market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global nanobiotechnology market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.


 
This report answers following key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for the global nanobiotechnology market by application (pharmaceuticals, medical devices, medical research, and others), therapeutics (dental therapies, cardiac therapies, orthopedic therapies, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global nanobiotechnology market?
Q.5 What are the business risks and threats to the global nanobiotechnology market?
Q.6 What are the emerging trends in this nanobiotechnology market and the reasons behind them?
Q.7 What are some changing demands of customers in this nanobiotechnology market?
Q.8 What are the new developments in this nanobiotechnology market? Which companies are leading these developments?
Q.9 Who are the major players in this nanobiotechnology market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this nanobiotechnology market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global nanobiotechnology market?

 


Report Scope



Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)
2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Application (Pharmaceuticals, Medical Devices, Medical Research, and Others) and Therapeutics (Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others)

Regional Scope

North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)

Customization 10% Customization without Any Additional Cost

Table of Contents
 
 
1. Executive Summary
 
2. Market Background and Classifications
2.1:Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
 
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Nanobiotechnology Market Trends and Forecast
3.3: Global Nanobiotechnology Market by Application
3.3.1: Pharmaceuticals
3.3.2: Medical Devices
3.3.3: Medical Research
3.3.4: Others
3.4: Global Nanobiotechnology Market by Therapeutics
3.4.1: Dental Therapies
3.4.2: Cardiac Therapies
3.4.3: Orthopedic Therapies
3.4.4: Others

4.Market Trends and Forecast Analysis by Region
4.1: Global Nanobiotechnology Market by Region
4.2: North American Nanobiotechnology Market
4.2.1: Market by Application: Pharmaceuticals, Medical Devices, Medical Research, and Others
4.2.2: Market by Therapeutics: Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others 
4.2.3: Market by Species: Fish, Crustaceans, and Mollusks
4.2.4: The United States Nanobiotechnology Market
4.2.5: The Canadian Nanobiotechnology Market
4.2.6: The Mexican Nanobiotechnology Market
4.3: European Nanobiotechnology Market
4.3.1: Market by Application: Pharmaceuticals, Medical Devices, Medical Research, and Others 
4.3.2: Market by Therapeutics: Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others 
4.3.3: The Nanobiotechnology Market of United Kingdom
4.3.4: The German Nanobiotechnology Market
4.3.5: The French Nanobiotechnology Market
4.4: APAC Nanobiotechnology Market
4.4.1: Market by Application: Pharmaceuticals, Medical Devices, Medical Research, and Others 
4.4.2: Market by Therapeutics: Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others 
4.4.3: The Chinese Nanobiotechnology Market
4.4.4: The Indian Nanobiotechnology Market
4.4.5: The Japanese Nanobiotechnology Market
4.5: ROW Nanobiotechnology Market
4.5.1: Market by Application: Pharmaceuticals, Medical Devices, Medical Research, and Others 
4.5.2: Market by Therapeutics: Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others 
4.5.3: Brazilian Nanobiotechnology Market

5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Nanobiotechnology Market by Application
7.1.2: Growth Opportunities for the Global Nanobiotechnology Market by Therapeutics
7.1.3: Growth Opportunities for the Global Nanobiotechnology Market by Region
7.2: Emerging Trends in the Global Nanobiotechnology Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Nanobiotechnology Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global NanobiotechnologyMarket
7.3.4: Certification and Licensing

8. Company Profiles of Leading Players
8.1: Aduro BioTech
8.2: Calando Pharmaceuticals Inc. 
8.3: Biosante Phosphate Pharmaceuticals Inc..
8.4: Celgene Corporation
8.5: Elan Pharmaceuticals Inc. 
8.6: Flamel Technologies Inc. 
8.7: Nanophase Technologies Corporation 
8.8: Sigma Aldrich Company
8.9: Dendritic Nanotechnologies Inc. 
8.10: SkyePharma Pharmaceuticals
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Nanobiotechnology Market: Trends, Forecast and Competitive Analysis Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Below is a brief summary of the primary interviews that were conducted by job function for this report.